ArticleJournal of oncology2019

Comparative Efficacy and Tolerability of Neoadjuvant Immunotherapy Regimens for Patients with HER2-Positive Breast Cancer: A Network Meta-Analysis.

Di Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.